Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;22(11):819-29.
doi: 10.1007/s10654-007-9199-x. Epub 2007 Oct 23.

The Rotterdam Study: objectives and design update

Albert Hofman  1 , Monique M B Breteler, Cornelia M van Duijn, Gabriel P Krestin, Huibert A Pols, Bruno H Ch Stricker, Henning Tiemeier, André G Uitterlinden, Johannes R Vingerling, Jacqueline C M Witteman
Affiliations

The Rotterdam Study: objectives and design update

Albert Hofman et al. Eur J Epidemiol. 2007.

Abstract

The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in the Netherlands. The study targets cardiovascular, neurological, ophthalmological and endocrine diseases. As of 2008 about 15,000 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in some 600 research articles and reports (see http://www.epib.nl/rotterdamstudy). This article gives the reasons for the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diagram of examination cycles of the Rotterdam Study (RS). RS1 refers to the baseline examination of the original cohort (pilot phase 07/1989-12/1989; cohort recruitment 01/1990-09/1993). RS2, RS3 and RS4 refer to re-examination of the original cohort members. RSPlus1 refers to the extension of the cohort with persons in the study district that became 55 years since the start of the study or those of 55 years or over that migrated into the study district. RSPlus2 refers to the re-examination of the extension cohort. RSYoung1 refers to the baseline examination of all persons aged 45 and over living in the study district that had not been examined (i.e. mainly comprising those aged 45–55 years)
See this image and copyright information in PMC

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1126/science.1069675', 'is_inner': False, 'url': 'https://doi.org/10.1126/science.1069675'}, {'type': 'PubMed', 'value': '12004104', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12004104/'}]}
    2. Oeppen J, Vaupel JW. Broken limits to life expectancy. Science 2002;296:1029–31. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC2127679', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2127679/'}, {'type': 'PubMed', 'value': '9366723', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9366723/'}]}
    2. Peto R, Doll R. There is no such thing as aging. BMJ 1997;315:1030–2. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/BF00145007', 'is_inner': False, 'url': 'https://doi.org/10.1007/bf00145007'}, {'type': 'PubMed', 'value': '1833235', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1833235/'}]}
    2. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Study. Eur J Epidemiol 1991;7:403–22. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '10681281', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10681281/'}]}
    2. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270–8. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.291.24.2969', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.291.24.2969'}, {'type': 'PubMed', 'value': '15213208', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15213208/'}]}
    2. Schuit SCE, Oei HHS, Witteman JCM, Geurts Van Kessel CH, Van Meurs JBJ, Nijhuis RL, Van Leeuwen JPTM, De Jong FH, Zillekens MC, Hofman A, Pols HAP, Uitterlinden AG. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA 2004;291:2969–77. - PubMed

Publication types